Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Postoperative Pain

In brief

This is a randomized, double-blinded, placebo-controlled trial to compare the effectiveness of IV oxytocin infusion to placebo on peri-operative opioid consumption and reducing post-operative pain following a minimally invasive hysterectomy under general anesthesia.

Key facts

Study ID
NCT06483659
Run by
Brigham and Women's Hospital
People needed
152
Starts
2025-06-01
Expected to finish
2026-12-01
Last updated by the study team
2025-12-30

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.